Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07NYF
|
||||
| Former ID |
DIB005893
|
||||
| Drug Name |
MLN-2201
|
||||
| Synonyms |
LDP-01; MLN-01; Anti-beta2-integrin MAb, LeukoSite
|
||||
| Drug Type |
Antibody
|
||||
| Indication | Cerebrovascular ischaemia [ICD9: 434.91; ICD10:I61-I63] | Discontinued in Phase 1 | [546763] | ||
| Company |
LeukoSite Inc
|
||||
| CAS Number |
CAS 339164-13-5
|
||||
| Target and Pathway | |||||
| Target(s) | Integrin beta-2 | Target Info | [546764] | ||
| KEGG Pathway | Rap1 signaling pathway | ||||
| Phagosome | |||||
| Hippo signaling pathway | |||||
| Cell adhesion molecules (CAMs) | |||||
| Natural killer cell mediated cytotoxicity | |||||
| Leukocyte transendothelial migration | |||||
| Regulation of actin cytoskeleton | |||||
| Pertussis | |||||
| Legionellosis | |||||
| Leishmaniasis | |||||
| Malaria | |||||
| Amoebiasis | |||||
| Staphylococcus aureus infection | |||||
| Tuberculosis | |||||
| HTLV-I infection | |||||
| Rheumatoid arthritis | |||||
| Viral myocarditis | |||||
| PANTHER Pathway | Integrin signalling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.